Source: Beckers Hospital Review

Lilly: Eli Lilly to make weight loss pill in US

Eli Lilly announced plans to manufacture its new weight loss pill, orforglipron, in the U.S., with global distribution set to begin in 2026, Bloomberg reported April 18. The move comes as President Donald Trump presses companies to shift to domestic production. "We're going to make this medicine here in the United States," CEO Dave Ricks [...] The post Eli Lilly to make weight loss pill in US appeared first on Becker's Hospital Review | Healthcare News & Analysis.

Read full article »
Annual Revenue
$10-50B
Employees
10-50K
David A. Ricks's photo - Chairman & CEO of Lilly

Chairman & CEO

David A. Ricks

CEO Approval Rating

80/100

Read more